A CLINICAL STUDY OF SIDDHA HERBAL PREPARATION – M V KASHAYAM FOR THE TREATMENT, CONTROL, AND MANAGEMENT OF COVID-19
Objective: At present, the pandemic COVID-19 by novel coronavirus causing severe mortality and losses to the human and no specific medicine to cure. Siddha is an ancient system of medicine used in using a variety of medicinal herbs to cure diseases of viral and unknown origin.
Method: The herbal medicine M V Kashayam prepared as per Siddha formula administered at the dose rate of 150 ml for every 6-h interval for Reverse Transcription–Polymerase Chain Reaction (RT – PCR) positive patients
Results: The prepared MV Kashayam can able to provide RT-PCR negative in 87.5% of cases within 4–6 days and 97.5% negatives in 12 days. The body temperature, Oxygen saturation level (SPO2), and respiration level become normal within 3 days.
Conclusion: The Siddha medicine, MV kashayam may be used as herbal medicine to treat the COVID-19 patients for earlier recovery and as a preventive measure to enhance immunity.
2. Thomas J. Medicinal and Aromatic Plant Research in India. In: Training Course on Industrial Exploitation of Indigenous Medicinal and Aromatic Plants. Beijing, China: UNDP, Proceeding; 1997. p. 17-27.
3. Panda D, Kumar DS, Kumar DG. Phytochemical examination and antimicrobial activity of various solvent extracts and the selected isolated compounds from roots of Tragia involucrata Linn. Int J Pharm Sci Drug Res 2012;4:44-8.
4. Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016;3:237-61.
5. Yousef A, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J Prev Med Hyg 2020;61:E304-12.
6. Malarkannan SP, Dharumaraj P. Anti-inflammatory activity of siddha preparation modivaer kashayam as a proposed remedy for management and treatment of Covid 19. Int J Res Anal Rev 2020;7:756-9.
7. Gupta SP. Statistical Methods. New Delhi: Sulthan Chand and Sons; 1997.
8. Jun Mi, Zhong W, Huang C, Zhang W, Tan L, Ding L. Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia. Am J Transl Res 2020;12:6537-48.
9. Preas HL, Jubran A, Vandivier RW, Reda D, Godin PJ, Banks SM, et al. Effect of endotoxin on ventilation and breath variability: Role of the cyclooxygenase pathway. Am J Respir Crit Care Med 2001;164:620-6.
10. Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319- 20.
11. Mark RG, David AG. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality, Med Hypotheses 2020;40:109760.
12. Arjun R, Duraisamy AJ, Selvakumar B, Pal SV. Medicinal plants from Siddha system of medicine useful for treating respiratory diseases. Int J Pharm Anal 2009;1:20-30.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.